CPHA Canvax

"Data on COVID-19 vaccinations reported to CDC from 50 states, the District of Columbia (DC), and eight territories and freely associated states were analyzed to ascertain coverage with booster or additional primary doses among adults aged ≥65 years. During August 13–November 19, 2021, 18.7 million persons aged ≥65 years received a booster or additional primary dose of COVID-19 vaccine, constituting 44.1% of 42.5 million eligible* persons in this age group who previously completed a primary vaccination series.† Coverage was similar by sex and age group, but varied by primary series vaccine product and race and ethnicity, ranging from 30.3% among non-Hispanic American Indian or Alaska Native persons to 50.5% among non-Hispanic multiple/other race persons. Strategic efforts are needed to encourage eligible persons aged ≥18 years, especially those aged ≥65 years and those who are immunocompromised, to receive a booster and/or additional primary dose to ensure maximal protection against COVID-19." - Booster and Additional Primary Dose COVID-19 Vaccinations among Adults Aged ≥65 Years—United States, August 13, 2021–November 19, 2021

Additional Authors: Lynn Gibbs Scharf, Carla L. Black, Lauren Shaw, Terence Chorba, LaTreace Q. Harris

Rating See Comments Ratings

Category:

Monitoring and Surveillance,Vaccine Monitoring and Surveillance,Outbreaks and Pandemics,Vaccination Coverage and Goals,COVID-19,Specific Populations,Adults,Seniors Monitoring and Surveillance
Vaccine Monitoring and Surveillance
Outbreaks and Pandemics
Vaccination Coverage and Goals
COVID-19
Specific Populations
Adults
Seniors

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.